Erratum: Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis (Mucosal Immunology (2014) 7 (1480-1491) DOI: 10.1038/mi.2014.36);Caspase-11 is expressed in the colonic mucosa and protects against dextran sodium sulfate-induced colitis

Mucosal Immunology

Volumn 7, Issue 6, 2014, Pages 1480-1491

  Demon, D ^a,b   Kuchmiy, A ^a,b   Fossoul, A ^a,b   Zhu, Q ^c   Kanneganti, T D ^c   Lamkanfi, M ^a,b  

^a DEPARTMENT OF PLANT SYSTEMS BIOLOGY   (Belgium)

^b GHENT UNIVERSITY   (Belgium)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 11; CXCL1 CHEMOKINE; DEXTRAN SULFATE; HIGH MOBILITY GROUP B1 PROTEIN; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; RANTES; CASP11 PROTEIN, MOUSE; CASPASE; IL1B PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL HOUSING; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL INFILTRATION; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEXTRAN SODIUM SULFATE-INDUCED COLITIS; DISEASE PREDISPOSITION; ENZYME DEFICIENCY; IMMUNE RESPONSE; INFLAMMATORY CELL; INTESTINE FLORA; MOUSE; NONHUMAN; PREVOTELLA; PROTEIN EXPRESSION; PYROPTOSIS; TISSUE INJURY; WILD TYPE; ANIMAL; CHEMICALLY INDUCED; COLITIS; COLON; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; INTESTINE MUCOSA; KNOCKOUT MOUSE; MICROBIOLOGY; PATHOLOGY;

ANIMALS; CASPASE 1; CASPASES; COLITIS; COLON; DEXTRAN SULFATE; GENETIC PREDISPOSITION TO DISEASE; INFLAMMASOMES; INTERLEUKIN-18; INTERLEUKIN-1BETA; INTESTINAL MUCOSA; MICE; MICE, KNOCKOUT; PREVOTELLA;

EID: 84908160928     PISSN: 19330219     EISSN: 19353456     Source Type: Journal    
DOI: 10.1038/mi.2014.83     Document Type: Erratum

References (32)

1. Jostins, L. et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature 491, 119-124 (2012).
2. Kitajima, S., Takuma, S. & Morimoto, M. Changes in colonic mucosal permeability in mouse colitis induced with dextran sulfate sodium. Exp. Anim. 48, 137-143 (1999).
3. Dieleman, L. A., Ridwan, B. U., Tennyson, G. S., Beagley, K. W., Bucy, R. P. & Elson, C. O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107, 1643-1652 (1994).
4. Lamkanfi, M. & Dixit, V. M. Inflammasomes and their roles in health and disease. Annu. Rev. Cell. Dev. Biol. 28, 137-161 (2012).
5. Villani, A. C. et al. Common variants in the NLRP3 region contribute to Crohn's disease susceptibility. Nat. Genet. 41, 71-76 (2009).
6. Zaki, M. H., Boyd, K. L., Vogel, P., Kastan, M. B., Lamkanfi, M. & Kanneganti, T. D. The NLRP3 inflammasome protects against loss of epithelial integrity and mortality during experimental colitis. Immunity 32, 379-391 (2010).
7. Allen, I. C. et al. The NLRP3 inflammasome functions as a negative regulator of tumorigenesis during colitis-associated cancer. J. Exp. Med. 207, 1045-1056 (2010).
8. Takagi, H. et al. Contrasting action of IL-12 and IL-18 in the development of dextran sodium sulphate colitis in mice. Scand. J. Gastroenterol. 38, 837-844 (2003).
9. Lebeis, S. L., Powell, K. R., Merlin, D., Sherman, M. A. & Kalman, D. Interleukin-1 receptor signaling protects mice from lethal intestinal damage caused by the attaching and effacing pathogen Citrobacter rodentium. Infect. Immun. 77, 604-614 (2009).
10. Kayagaki, N. et al. Non-canonical inflammasome activation targets caspase-11. Nature 479, 117-121 (2011).
11. Rathinam, V. A. et al. TRIF licenses caspase-11-dependent NLRP3 inflammasome activation by gram-negative bacteria. Cell 150, 606-619 (2012).
12. Broz,P. et al. Caspase-11 increases susceptibility to Salmonella infection in the absence of caspase-1. Nature 490, 288-291 (2012).
13. Aachoui, Y. et al. Caspase-11 protects against bacteria that escape the vacuole. Science 339, 975-978 (2013).
14. Dupaul-Chicoine, J. et al. Control of intestinal homeostasis, colitis, and colitis-associated colorectal cancer by the inflammatory caspases. Immunity 32, 367-378 (2010).
15. Chassaing, B. & Darfeuille-Michaud, A. The commensal microbiota and enteropathogens in the pathogenesis of inflammatory bowel diseases. Gastroenterology 140, 1720-1728 (2011).
16. Xavier, R. J. & Podolsky, D. K. Unravelling the pathogenesis of inflammatory bowel disease. Nature 448, 427-434 (2007).
17. Brinkman, B. M. et al. Gut microbiota affects sensitivity to acute DSSinduced colitis independently of host genotype. Inflamm. Bowel. Dis. 19, 2560-2567 (2013).
18. Elinav, E. et al. NLRP6 inflammasome regulates colonic microbial ecology and risk for colitis. Cell 145, 745-757 (2011).
19. Rakoff-Nahoum, S., Paglino, J., Eslami-Varzaneh, F., Edberg, S. & Medzhitov, R. Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118, 229-241 (2004).
20. Qiu, W. et al. PUMA-mediated intestinal epithelial apoptosis contributes to ulcerative colitis in humans and mice. J. Clin. Invest. 121, 1722-1732 (2011).
21. Lamkanfi, M. Emerging inflammasome effector mechanisms. Nat. Rev. Immunol. 11, 213-220 (2011).
22. Lu, B., Wang, H., Andersson, U. & Tracey, K. J. Regulation of HMGB1 release by inflammasomes. Protein Cell 4, 163-167 (2013).
23. Siegmund, B. et al. Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production. Am. J. Physiol. Regul. Integr. Comp. Physiol 281, R1264-R1273 (2001).
24. Hugot, J. P. et al. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411, 599-603 (2001).
25. Ogura, Y. et al. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411, 603-606 (2001).
26. Girardin, S. E. et al. Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection. J. Biol. Chem. 278, 8869-8872 (2003).
27. Inohara, N. et al. Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease. J. Biol. Chem. 278, 5509-5512 (2003).
28. Lamkanfi, M., Kalai, M. & Vandenabeele, P. Caspase-12: an overview. Cell Death Differ. 11, 365-368 (2004).
29. Gurung, P. et al. TRIF-mediated caspase-11 production integrates TLR4-and Nlrp3 inflammasome-mediated host defense against enteropathogens. J. Biol. Chem. 287, 34474-34483 (2012).
30. Kuida, K. et al. Altered cytokine export and apoptosis in mice deficient in interleukin-1 beta converting enzyme. Science 267, 2000-2003 (1995).
31. Vlantis, K. et al. Constitutive IKK2 activation in intestinal epithelial cells induces intestinal tumors in mice. J. Clin. Invest. 121, 2781-2793 (2011).
32. Anand, P. K. et al. NLRP6 negatively regulates innate immunity and host defence against bacterial pathogens. Nature 488, 389-393 (2012).